News | April 16, 2018

Harpoon Therapeutics Launches Immuno-Oncology Pipeline with Compelling Data from Lead Programs at the 2018 American Association for Cancer Research (AACR) Annual Meeting Preclinical Data Showcase New T Cell Engaging Platform (TriTACâ„¢) and Lead Drugs, HPN424 and...

News | April 4, 2018

Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform Financing round led by Nextech Invest. Proceeds to advance lead oncology programs into the clinic and broaden early-stage pipeline NEW HAVEN, CT, April 4, 2018 – Arvinas LLC, a...
neque. in id, amet, Aenean suscipit consectetur tempus luctus sem, ultricies fringilla